Musgrove Park Hospital

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Nicholas D. James, Matthew R. Sydes, Noel W. Clarke et al. · The Lancet · 2015 · 1.9K citations · Full text

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

Nicholas D. James, Johann S. de Bono, Melissa Spears et al. · New England Journal of Medicine · 2017 · 1.7K citations · Full text

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

David P. Dearnaley, Isabel Syndikus, Helen Mossop et al. · The Lancet Oncology · 2016 · 1.3K citations · Full text

Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018

Richard Welbourn, Marianne Hollyman, Robin Kinsman et al. · Obesity Surgery · 2018 · 800 citations · Full text

Obesity, Bariatric Surgery, Bariatric Surgery Worldwide +12

Gut Hormones as Mediators of Appetite and Weight Loss After Roux-en-Y Gastric Bypass

Carel W. le Roux, Richard Welbourn, Malin Werling et al. · Annals of Surgery · 2007 · 728 citations